The IBN SINA Pharmaceutical Industry PLC announcements
340 Dhaka Stock Exchange announcements for The IBN SINA Pharmaceutical Industry PLC (IBNSINA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2017 (34).
- Buy confirmation of a Nominated Director
Mr. Kazi Harun-Or-Rashid, one of the Directors of the Company, (Nominated Director by Ibn Sina Trust), has further reported that he has completed his buy of 7,750 shares of the Company at prevailing market price through Stock Exchange as announced earlier.
- Buy declaration of a Nominated Director
Mr. Kazi Harun-Or-Rashid, one of the Directors of the Company, (Nominated Director by Ibn Sina Trust), has expressed his intention to buy 7,750 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange (DSE) within next 30 working days.
- Buy Confirmation of a Director (Nominated by Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Nominated by IBN Sina Trust) of the Company, has further reported that he has completed his Buy of 3,000 shares of the Company at prevailing market price through Stock Exchange as announced earlier.
- Buy Declaration of a Director (Nominated Director by Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Nominated Director by IBN Sina Trust) of the Company, has expressed his intention to buy 3,000 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange within next 30 working days.
- Buy Confirmation of a Director (Nominated Director by Ibn Sina Trust)
Mr. Kazi Harun-or-Rashid, one of the Directors of the Company, (Nominated Director by Ibn Sina Trust), has further reported that he has completed his buy of 12,000 shares of the Company at prevailing market price through Stock Exchange as announced earlier.
- Dividend Disbursement
The Company has informed that it has credited the Bonus shares for the year ended on June 30, 2017 to the respective shareholders' BO Accounts on November 30, 2017. Cash dividend for the year ended on June 30, 2017 will be disbursed to the respective shareholders through EFT, Banking Channel and Registered courier as per rule.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 2.39 for July-September, 2017 as against Tk. 1.67 for July-September, 2016. NOCFPS was Tk. 4.97 for July-September, 2017 as against Tk. 0.91 for July-September, 2016. NAV per share was Tk. 46.07 as on September 30, 2017 and Tk. 42.79 as on June 30, 2017.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2017 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.
- Buy declaration of a Nominated Director
Mr. Kazi Harun-or-Rashid, one of the Directors of the Company, (Nominated Director on behalf of Ibn Sina Trust), has expressed his intention to buy 12,000 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange within next 30 working days.
- Resumption after Record Date
Trading of the shares of the Company will resume on 23.10.2017 after record date.
- Suspension for Record Date
Trading of the shares of the Company will remain suspended on record date i.e., 22.10.2017.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefits from 18.10.2017 to 19.10.2017. Trading of the shares of the Company will remain suspended on record date i.e., 22.10.2017.
- Buy Confirmation of a Director (Representative of Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Representative of IBN Sina Trust) of the Company, has further reported that he has completed his buy of 2,000 shares of the Company at prevailing market price through Stock Exchange as announced earlier.
- Buy Declaration of a Director (Representative of Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Representative of IBN Sina Trust) of the Company, has expressed his intention to buy 2,000 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange within next 30 working days.
- Dividend Declaration
The Board of Directors has recommended 25% Cash dividend and 10% Stock Dividend for the year ended on June 30, 2017. Date of AGM: 22.11.2017, Time of AGM: 9:30 AM, Venue of the AGM: Emmanuell's Convention Center, Shimanto Square Market (Rifles Square) 5th Floor, Dhanmondi, Dhaka. Record Date: 22.10.2017. (cont.) (Continuation news of IBNSINA): The Company has also reported EPS of Tk. 9.06, NAV per share of Tk. 42.79 and NOCFPS of Tk. 4.82 for the year ended on June 30, 2017 as against Tk. 7.85, Tk. 33.67 and Tk. 14.92 respectively for the same period of the previous year. (end)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (26.09.2017) following its corporate declaration.
- Land Purchase
The Company has informed that as per approval of Bangladesh Small and Cottage Industries Corporation (BSCIC) authority, Government of Bangladesh, the Board of Directors of the Company has decided to purchase a land measuring area of 1.52 acres at BSCIC API Industrial Park, Gozaria, Munshi Gonj, Bangladesh at a cost of Tk. 7,16,78,801.00 to be paid within 10 years in 10 equal instalments at the rate of Tk. 71,67,881.00 for establishment of a plant of Active Pharmaceutical Ingredients (API).
- Reschedule of Board Meeting under LR 19(1)
The Company has further informed that due to unavoidable circumstances, meeting of the Board of Directors of the Company as per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will now be held on September 25, 2017 at 3:00 PM instead of September 10, 2017 to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on September 10, 2017 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.
- Land Purchase
The Company has informed that the Board of Directors has decided to purchase approximately 11.66 acre land at Dhonia, Shripur, Gazipur with total cost of Tk. 4.50 crore excluding registration fees and other related cost.
- Buy Confirmation of a Director (Representative of Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Representative of IBN Sina Trust) of the Company, has further reported that he has completed his buy of 1,000 shares of the Company at prevailing market price through Stock Exchange, as announced earlier.
- Buy Declaration of a Director (Representative of Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Representative of IBN Sina Trust) of the Company, has expressed his intention to buy 1,000 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange within April 30, 2017.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 1.52 for January-March, 2017 as against Tk. 1.51 for January-March, 2016; EPS was Tk. 7.14 for July, 2016-March, 2017 as against Tk. 6.31 for July, 2015-March, 2016. NOCFPS was Tk. 4.75 for July, 2016-March, 2017 as against Tk. 8.09 for July, 2015-March, 2016. NAV per share was Tk. 44.30 as of March 31, 2017 and Tk. 33.67 as of June 30, 2016.
- Sponsors' share portion increase in the Ibn Sina Consumer Products Ltd.
The Company has informed that the Board of Directors has decided that the Sponsors' share portion of The Ibn Sina Pharmaceuticals Limited in the Ibn Sina Consumer Products Limited will be increased to 40% from existing 35%.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 20, 2017 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.
- Buy Confirmation of a Director (Representative of Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Representative Director of IBN Sina Trust) of the Company, has further reported that he has completed his buy of 1,000 shares of the Company at prevailing market price through Stock Exchange, as announced earlier.
- Buy Declaration of a Director (Representative of Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Representative Director of IBN Sina Trust) of the Company, has expressed his intention to buy 1,000 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange within April 30, 2017.
- Buy confirmation of a Director (Representative of Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Representative on behalf of IBN Sina Trust) of the Company, has further reported that he has completed his buy of 1,000 shares of the Company at prevailing market price through Stock Exchange, as announced earlier.
- Credit Rating Result
Credit Rating Agency of Bangladesh Limited (CRAB) has announced the entity rating of the Company as "A2" along with a stable outlook based on audited financial statements up to June 30, 2016, bank liability position as on February 28, 2017 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Buy Declaration of a Director (Representative of Ibn Sina Trust)
Mr. M. Ataur Rahman, one of the Directors (Representative on behalf of IBN Sina Trust) of the Company, has expressed his intention to buy 1,000 shares of the Company at prevailing market price (in the Public Market) through Stock Exchange within next 30 working days.
- Land Purchase
The Company has informed that the Board of Directors has decided to purchase approximately 3.50 acre land with a total cost of Tk. 2.80 crore excluding registration and other related cost at Valuka, Mymensingh.
- Buy Confirmation
Kazi Harun-or-Rashid, one of the Directors of the Company, (Representative Director on behalf of Ibn Sina Trust), has further reported that he has completed his buy of 30,000 shares of the Company through Stock Exchange as announced earlier.
- Q2 Financials
EPS was Tk. 3.95 for October-December, 2016 as against Tk. 3.82 for October-December, 2015; EPS was Tk. 5.62 for July-December, 2016 as against Tk. 4.80 for July-December, 2015. NOCFPS was Tk. 3.22 for July-December, 2016 as against Tk. 6.40 for July-December, 2015. NAV per share was Tk. 38.40 as of December 31, 2016 and Tk. 33.67 as of December 31, 2015
- Board Meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 23, 2017 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.